ARADyAL: The Spanish Multidisciplinary Research Network for Allergic Diseases.

Area of Science:

• Allergy and Immunology
• Pharmacology
• Genetics
• Nanomedicine

Background:

• Thematic cooperative health research networks (RETICS) aim to address societal health challenges through collaborative research.
• The Asthma, Adverse Drug Reactions, and Allergy (ARADyAL) network, funded 2017-2021, integrates basic and clinical research in allergy and related fields.
• ARADyAL comprises 28 Spanish groups with 171 researchers, including 17 clinical groups serving over 10 million patients.

Purpose of the Study:

• To conduct cooperative research projects focused on challenges in allergy, adverse drug reactions, and allergic diseases.
• To advance precision medicine approaches for allergic diseases, including severe phenotypes.
• To foster collaboration between basic scientists and clinicians in allergy research.

Main Methods:

• Integrating basic and clinical research across disciplines like immunology, genetics, nanomedicine, pharmacology, and chemistry.
• Focusing on identifying new biomarkers and designing/evaluating novel interventions for allergic patients.
• Organizing research into three programs: disease mechanisms/prediction, precise diagnosis, and intervention prediction, plus a training program.

Main Results:

• Established a network of 28 research groups across Spain, involving 171 clinical and basic researchers.
• Engaged 17 clinical groups covering a large patient population across diverse geographical areas.
• Proposed a structured research program centered on precision medicine for allergic diseases.

Conclusions:

• ARADyAL serves as a vital platform for interdisciplinary collaboration in allergy research.
• The network is dedicated to advancing the understanding and treatment of allergic diseases through a precision medicine framework.
• The collaborative structure aims to translate research findings into improved healthcare for patients with allergies.